Radiation oncologist Adeel Kaiser, M.D., joins Miami Cancer Institute
“We are pleased to welcome Dr. Kaiser to Miami Cancer Institute,” said Leonard Kalman, M.D., executive deputy director and chief medical officer at Miami Cancer Institute. “Dr. Kaiser’s clinical expertise, experience and clinical research background will make him an asset to our organization.”
Dr. Kaiser joins Miami Cancer Institute from the University of Maryland Department of Radiation Oncology, where he served as the director of the Advanced Modalities Fellowship Program. This program trained national and international students in emerging radiation oncology modalities, including pencil beam proton therapy, GammaPod radiosurgery and deep tissue hyperthermia. Dr. Kaiser also served as the director of the Integrative Wellness Program at the Maryland Proton Treatment Center, which sought to incorporate diet, exercise and emotional support strategies with radiation therapy.
Dr. Kaiser is widely published in peer-reviewed medical journals. He has led multiple clinical trials and was the first radiation oncologist to lead a ketogenic diet trial for patients under active surveillance for prostate cancer. He has received numerous awards for his work, including grant awards from industry and National Institutes of Health-sponsored institutions for both laboratory and clinical research in metabolic therapy. He holds an adjunct position at the University of Maryland while serving as principal investigator for a grant-supported pre-clinical study of a novel glycolytic inhibitor.
Dr. Kaiser earned his medical degree from Johns Hopkins University School of Medicine. He completed his internship in internal medicine at the University of Chicago and his residency in radiation oncology at the University of California, Irvine. He is fluent in English, Urdu and Hindi.
He will see patients at Miami Cancer Institute, located at 8900 N. Kendall Drive, in Miami.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology program in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
# # #
